Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort

Authors

Tomi Akinyemiju, Duke University School of Medicine
Justin X. Moore, Washington University School of Medicine in St. Louis
Maria Pisu, University of Alabama at Birmingham
Michael Goodman, Emory University Rollins School of Public Health
Virginia J. Howard, University of Alabama at Birmingham
Monika Safford, Weill Cornell Medical College
Susan C. Gilchrist, The University of Texas MD Anderson Cancer Center
Mary Cushman, Larn er College of Medicine at the University of Vermont
LeAnn Long, University of Alabama at Birmingham
Suzanne E. Judd, University of Alabama at Birmingham

Journal

Oncotarget

Publication Date

8-6-2019

Volume

10

Issue

47

First Page

4857

Last Page

4867

Document Type

Open Access Publication

DOI

10.18632/oncotarget.27108

Rights and Permissions

Akinyemiju T, Moore JX, Pisu M, Goodman M, Howard VJ, Safford M, Gilchrist SC, Cushman M, Long L, Judd SE. Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort. Oncotarget. 2019 Aug 6;10(47):4857-4867. doi: 10.18632/oncotarget.27108. eCollection 2019 Aug 6. Copyright: Akinyemiju et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Akinyemiju, Tomi; Moore, Justin X.; Pisu, Maria; Goodman, Michael; Howard, Virginia J.; Safford, Monika; Gilchrist, Susan C.; Cushman, Mary; Long, LeAnn; and Judd, Suzanne E., "Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort." Oncotarget. 10, 47. 4857 - 4867. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8821